Vasuda Capital Management announces launch of Vasuda Life Sciences Index

NEWBURYPORT, Mass. - Aug. 22, 2014 - PRLog -- Vasuda Capital Management (vasudacapitalmanagement.com), a Greater Boston based investment management firm has announced the launch of Vasuda Life Sciences Index. The index is a basket of 20-30, innovative, publicly traded companies in the life sciences sector (biotech, pharma, medical devices) in optimized portfolio sizes based on the firm's proprietary model. The firm plans to file for an ETF based on the index.

Vasuda Capital Management runs Vasuda Life Sciences Fund, a hedge fund which combines Vasuda Life Science Index with aggressive hedging in market downtrends to amplify portfolio return. The Fund has returned 25% in 3.5 months since the inception outperforming the S&P 500 index. The firm was funded by Bhavneesh Sharma, MD, MBA (NYU-Stern, Finance). The Fund invests both long and short in the life sciences sector to take advantage of significnt disparities that exist between market prices and fundamentally driven valuations throughout the business cycle. The minimum Investment in the Fund is $ 1 million.